• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Authors


Jeffrey Botbyl, MS

Latest:

Predicting Drug-Drug and Drug-Gene Interactions in a Community Pharmacy Population

The probability of drug interactions increases when genetic polymorphisms are considered, indicating that pharmacogenetic assessment may be useful in predicting the presence and severity of interactions.


Cameron Adams, MPP

Latest:

Patient Assignment and Quality Performance: A Misaligned System

This article explores the congruence between payer patient assignment and quality performance and the implications for incentive payments in alternative payment models.


Andrew W. Roberts, PharmD, PhD

Latest:

Trends in Medicare Part D Coverage of Generics With Equivalent Brand-Name Drugs

High-tier generic drug placement in Medicare Part D has increased over time, but it may be related to a drug’s clinical profile and availability of substitutes rather than preferred brand-name drug coverage.


Yueming Zhao, MPH

Latest:

Spending Patterns Among Commercially Insured Individuals During the COVID-19 Pandemic

In this analysis of more than 97 million commercially insured individuals, investigators found that the COVID-19 pandemic induced a spending shock in 2020 and that health care spending did not recover to baseline until mid-2021.


Keith A. Horvath, MD

Latest:

What Value Do Teaching Hospitals Provide Commercial Beneficiaries When in an ACO?

Accountable care organizations (ACOs) with a major teaching hospital were associated with lower mortality, lower inpatient spending, lower emergency department utilization, and higher overall outpatient spending.


Michael R. Richards, MD, PhD, MPH

Latest:

Removing Medicare’s Outpatient Ban and Medicare and Private Surgical Trends

This article documents a 100% increase in privately insured outpatient knee replacement surgeries following Medicare’s decision to remove knee replacements from its Inpatient Only list.


Blair Burnett, BA

Latest:

Considerations to Increase Rates of Breast Cancer Screening Across Populations

Authors from the Community Oncology Alliance and Avalere Health present data that show breast cancer screening rates recovered more slowly among some racial/ethnic groups following on the onset of the COVID-19 pandemic.


Adam Matsil, MS

Latest:

Primary Care Visit Cadence and Hospital Admissions in High-Risk Patients

Patients with congestive heart failure and/or chronic obstructive pulmonary disease who had more quarterly primary care visits had lower rates of hospitalizations during the COVID-19 pandemic.


Joyce Wang

Latest:

Contributor: Providers and Patients Push Back, Payers Push Forward—Co-pay Mitigation Programs

Research shows how commercial health plans impact payer trends in the co-pay landscape and provides key areas that pharmaceutical and biotech manufacturers can explore to ensure patient access.



Sourya Sourabh Mohakuda, MD

Latest:

Clinical Profile of COVID-19 Infection in Postvaccination Individuals

This article describes the findings of an observational study carried out in India to examine the clinical profile of individuals detected to be COVID-19 positive post vaccination.


Jean L. Raphael, MD

Latest:

TCD Screening and Spending Among Children With Sickle Cell Anemia

A substantial proportion of families of privately insured children with sickle cell anemia pay more than $100 for essential stroke screenings, a high-value service.


Scott A. Soefje, PharmD

Latest:

Neulasta Onpro: A Coup de Grâce?

With the rapid decline in average sales price of reference pegfilgrastim products due to biosimilar competition, health care institutions and payers may grapple with coverage of Neulasta Onpro.



Alexa N. Fiffick, DO, MBS, MSCP

Latest:

Safety Profiles of Neurokinin-Targeted Therapies for VMS

Panelists discuss the notable adverse events observed in the OASIS trials with elinzanetant and compare the safety profiles of elinzanetant and fezolinetant with those of traditional treatments for vasomotor symptoms (VMS).


Mark Stephens, MD

Latest:

Mobile Health Clinic: Lessons Learned Building Partnerships Across Health Systems

Establishing mobile health clinics in rural settings requires collaboration across health systems by aligning missions, building infrastructure to support research, and demonstrating proof of concept.


Vannessa Harrison, DrPH

Latest:

Hospital Discharge Diagnosis Position: Impact on Adult Pneumonia Burden Estimates

Disease burden estimates of pneumonia-associated hospitalizations are more sensitive when including pneumonia coded in any diagnosis field vs in only the first discharge diagnosis field.


Edward Juhn, MD, MBA, MPH

Latest:

Incentivizing Data Sharing Among Health Plans, Hospitals, and Providers to Improve Quality

Health plans can gain efficiencies and improve quality by connecting to health information networks and incentivizing hospital and provider participation as part of pay-for-performance programs.


Lucy Tu, AB

Latest:

Financial Crossroads of Care: Physicians’ Struggle and Patient Outcomes

In 2024, physicians face significant financial challenges due to declining Medicare reimbursement rates and high student loan interest rates, which will impact health care delivery and access.


Allison L. Cipriani, MD

Latest:

Statin Prescribing Patterns in Patient-Centered Medical Home Patients With NAFLD

In this study, authors assessed the proportion of patients with nonalcoholic fatty liver disease (NAFLD) receiving prescriptions for statins in primary care.


Stella K. Kang, MD, MSc

Latest:

When Does Nonadherence Indicate a Deviation From Patient-Centered Care?

The authors suggest that assessment of patient-centered care may be improved by flagging probable discordance between a patient’s preferences and their treatment care plan.


Gregory B. Russell, MS

Latest:

Primary Care Referrals to Nephrology in Patients With Advanced Kidney Disease

Primary care physicians did not refer the majority of patients with severe nephropathy to specialists; nonreferred patients had fewer comorbidities and might be better kidney transplant candidates.


Jacob E. Kurlander, MD, MS

Latest:

Interest in and Concerns About Telehealth Among Adults Aged 50 to 80 Years

In this survey of adults aged 50 to 80 years, sociodemographic factors, as well as experience with video chat, were associated with interest in and concerns about telehealth video visits.


Brian P. Mulherin, MD

Latest:

Financial Considerations Influencing Treatment Strategies in PNH Treatment Pathway

The panelists provide their final thoughts, highlighting financial considerations in PNH treatment.


Chiao-Li Chan, MSW

Latest:

Evaluating Alternative Methods of Comparing Antihypertensive Treatment Intensity

Medication dose captures modification of hypertension treatment intensity more precisely than medication count, and this measure should be preferred in studies that aim to improve hypertension management.


Chau Truong, MPH

Latest:

Evaluation of a Collaborative Model Between Managed Care and Affordable Housing on Acute Care Costs

A collaborative service model between a managed care organization and an affordable housing provider reduced acute care use and costs.


Dolly Sharma, PhD

Latest:

Cost of Home vs Clinic Administration of Paclitaxel in Metastatic Breast Cancer

Home administration of oral paclitaxel and encequidar is associated with potential cost savings for payers compared with clinic administration of intravenous chemotherapy in metastatic breast cancer patients.


Amiee Kang, MPH

Latest:

Journey to Anticoagulant Access Following Payer Rejection of Apixaban

Formulary restrictions can create treatment barriers for patients with atrial fibrillation, including unnecessary delays in treatment and prescription abandonment, with vulnerable populations at greater risk.


Jai Seth, MSc

Latest:

Leveraging Patient Activation to Improve Kidney Health in High-Risk Patients

Frequency of patient-provider conversations and patient activation are the 2 most significant predictors of a high-risk patient’s behaviors to prevent kidney disease.

© 2024 MJH Life Sciences
AJMC®
All rights reserved.